Clinical Trial Update: Effectiveness of PEA Compared to Placebo on Acute Menstrual Pain [Phase 4]

View source ↗

Summary

Phase 4 trial comparing palmitoylethanolamide (PEA) to placebo for acute dysmenorrhea has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dysmenorrhea

Drugs mentioned

• Palmitoylethanolamide (PEA) (palmitoylethanolamide)

Snippet

Sponsor: RDC Clinical Pty Ltd | Conditions: Menstrual Pain | Phase 4 | Status: COMPLETED